Target intelligence / Profile preview

D-alanyl-D-alanine moiety of peptidoglycan precursor (D-Ala-D-Ala)

Target
D-Ala-D-Ala
Molecular classification
Other (structural motif), Antibiotic binding site, Peptidoglycan precursor
01

Overview

The **D-alanyl-D-alanine moiety of peptidoglycan precursor** is a dipeptide structure found at the terminal end of the pentapeptide stem in peptidoglycan precursors of most Gram-positive and Gram-negative bacteria. It serves as the critical substrate for the transpeptidase enzymes (also known as penicillin-binding proteins), which cross-link the peptide stems and form the rigid, mesh-like cell wall. This moiety is the specific binding site for glycopeptide antibiotics such as vancomycin, which inhibit cell wall biosynthesis by forming stable complexes with the D-Ala-D-Ala dipeptide, thereby blocking access of transpeptidases and preventing proper cell wall cross-linking. Modification of this moiety to D-Ala-D-Lac or D-Ala-D-Ser is a known mechanism of resistance in clinical pathogens, dramatically reducing antibiotic binding affinity. The D-Ala-D-Ala motif is critical for bacterial survival, cell shape maintenance, and rigidity, and its biosynthesis involves dedicated ligases that join two D-alanine residues before attachment to the growing peptidoglycan chain. The presence or replacement of D-Ala-D-Ala is a key biomarker for antibiotic susceptibility and resistance in bacterial infections.

Other names
D-Ala-D-Ala dipeptideD-alanyl-D-alanine terminusD-Ala-D-Ala endD-alanine-D-alanine moiety
02

Mechanism of action

Inhibition of peptidoglycan cross-linking by direct binding to D-Ala-D-Ala, blocking transpeptidase activity (vancomycin and similar glycopeptides)\nCompetitive inhibition of D-Ala-D-Ala ligase by structural mimicry (β-lactams and D-cycloserine)

03

Biological functions

Peptidoglycan biosynthesisCell wall constructionStructural integrity of bacterial cell wall
04

Disease associations

Infection (target in antibacterial drug resistance and susceptibility)
05

Safety considerations

Development of resistance through replacement/modification of D-Ala-D-Ala with D-Ala-D-Lac or D-Ala-D-Ser reduces binding affinity for glycopeptide antibiotics, leading to therapeutic failureNo direct safety concerns for the target itself, but targeting can cause disruption of gut flora and secondary infections (general concern for cell wall-active antibiotics)
06

Interacting drugs

Vancomycin

5 more in the full profile.

07

Biomarkers

Presence of D-Ala-D-Ala end in bacterial cell wall precursors (for susceptibility to glycopeptide antibiotics)Detection of modified ends (D-Ala-D-Lac, D-Ala-D-Ser) as markers of resistance

Beyond the preview

Go deeper on D-alanyl-D-alanine moiety of peptidoglycan precursor (D-Ala-D-Ala).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on D-alanyl-D-alanine moiety of peptidoglycan precursor (D-Ala-D-Ala).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call